3//SEC Filing
Richard King Mellon Foundation 3
Accession 0000899243-19-012562
CIK 0001563880other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 7:01 PM ET
Size
4.8 KB
Accession
0000899243-19-012562
Insider Transaction Report
Form 3
Richard King Mellon Foundation
10% Owner
Holdings
Series C Preferred Stock
→ Common Stock (222,750 underlying)
Footnotes (1)
- [F1]The Series C Preferred Stock and the dividends that have accrued thereon to date are convertible on a 9.5-for-one basis into the number of shares of Common Stock shown in Column 3 without payment of further consideration at the holder's election or automatically upon the closing of the Issuer's initial public offering. The number of shares of Common Stock into which the Series C Preferred Stock and accrued dividends thereon are convertible will increase on a daily basis without payment of further consideration as additional dividends accrue. The shares have no expiration date.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
IncorporatedPA
Related Parties
1- filerCIK 0001774767
Filing Metadata
- Form type
- 3
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 7:01 PM ET
- Size
- 4.8 KB